Search

Despite a late-week sell-off, stocks finished the week with a mixed but telling tape. Federal Reserve policymakers delivered a widely anticipated 25 basis-point rate cut mid-week — reinforcing easier policy expectations — while fresh highs in cyclicals and small caps early in the week signaled strong breadth, only to be met by renewed AI valuation angst into Friday. Rotation out of mega-cap tech and into value names helped buoy the Dow and Russell 2000 which gained 1% and 0.5%, respectively, even as the tech-heavier S&P 500 and Nasdaq fell 0.6% and 1.6%.

Led higher by the Russell 2000 (IWM), which gained 3% on the week, the leading indexes saw extreme rotation, but closed the week higher as the S&P 500 rose by 1%, the Dow added 1.7%, and the Nasdaq gained 0.8%.

Led higher by the Russell 2000 (IWM), which gained 3% on the week, the leading indexes saw extreme rotation, but closed the week higher as the S&P 500 rose by 1%, the Dow added 1.7%, and the Nasdaq gained 0.8%.

The Fed raised benchmark interest rates a half a point and signaled more to come. Elsewhere, scientists studying fusion energy at Lawrence Livermore National Laboratory have crossed a huge milestone in reproducing the power of the sun in a laboratory. Explorer positions showed relative strength, led again by Kraken (KRNKF). Today we go to Britain for a historic and strategically important company, brand, and stock selling for a bit over $1 a share.

The Federal Reserve resumed lifting interest rates Wednesday with a quarter-percentage-point increase that brings interest rates to a 22-year high. The decision was unanimous.

The benchmark federal funds rate will go to a range between 5.25% and 5.5% as the Fed continues its fight against inflation. This is the 11th increase since March 2022, when rates were near zero.

Inflation has already retreated from a four-decade high last summer and the consumer-price index was up 3% in June year over year which is much lower than the June 2022 peak of 9.1%.

Not much has changed in our portfolio, though Home Depot (HD) did report solid earnings on Tuesday.

The sellers finally showed up today, with some negative headlines causing the market to pull back. In the Model Portfolio, we’re standing pat tonight with 35% in cash, though we’re spying a few names for possible new buying.

Remain bullish. The market continues to act well, and while the broad market has been futzing around for nearly a month, our market timing indicators are positive and most leading stocks are in good shape. Only change tonight is putting one position back on Buy.

Current Market Outlook


The major indexes found some decent support last week, rallying back to the top of their ranges, but overall they’re still thrashing around in the same range they’ve occupied since early August, keeping the intermediate-term trend sideways-to-down. The one thing that did change late last week was a bout of rotation, with money flowing into the beaten-down areas (financials, transports, energy, etc.); it’s something to keep an eye on, but we can’t say it’s a new trend quite yet. All in all, the market is showing us a lot of movement, but little net progress—and thus, our overall advice hasn’t changed. We’re keeping our Market Monitor at a level 5, meaning you should be choosy and keep things small on the buy side, while holding some cash and honoring stops and loss limits with your weaker performers.

The good news, as it has been all year, is that there remain many stocks that looks ready to enjoy meaningful upmoves if the market can get its act together. Our Top Pick is New Oriental Education (EDU), a rare China-related stock that’s making new highs on good volume.

Stock Name	Price	Buy Range	Loss Limit
Burlington Stores (BURL)	193.95	195-198	179-182
Jacobs Engineering Group (JEC)	89.83	86-88	79.5-81
Meritage Homes (MTH)	102.20	63-66	57.5-59
Neurocrine Biosciences (NBIX)	123.40	95.5-98.5	88-90
New Oriental Education (EDU)	113.97	106-108	98-100
Take-Two Interactive (TTWO)	123.32	129-133	120-122
Tandem Diabetes (TNDM)	74.77	67-70	60-62
Trex Company (TREX)	117.56	80-83	74-76
Twitter (TWTR)	40.37	40.5-42.5	37-38
Wheaton Precious Metals (WPM)	34.43	28-29	25.5-26.5

Our portfolio advanced this week led by India’s ICICI (IBN), which was up 19% on the back of a tax cut and prospects for higher growth.

Banking crisis fears have subsided, and while the fallout from Silicon Valley Bank, Silvergate and Signature Bank simultaneously going under is sure to be felt in the market for weeks and months to come, it’s also not looking like 2008 out there, at least not at the moment. Still, we could use some more safety in the portfolio, and today we add it in the form of a large-cap healthcare giant that’s a reliable dividend payer, boasts one of the industry’s best drug pipelines, and has been outperforming the market for years. It’s a favorite of Cabot Dividend Investor Chief Analyst Tom Hutchinson, who recently upgraded the stock to Buy.

This year has been about as choppy and tricky as we can remember, so nothing the market would throw at us from here would come as a surprise. That said, there’s no question the snapback of the past couple of weeks has been very encouraging—the major indexes have rebounded beautifully, with many regaining their 50-day lines, and individual stocks (especially growth stocks) have done great, with more and more moving back to (or out above) their prior highs. We also like that the bounce has been broad, with the on-again, off-again, rotational action taking a backseat to outright buying. Obviously, the market isn’t totally out of the woods, as most indexes are still range-bound and earnings season is upon us, which will often change the trajectory of things. But we always go with what we see, and the odds are increasing that the September/early October correction is over. We’re moving our Market Monitor back up to a level 7, and could go higher than that if the good vibes continues.

This week’s list represents the broad advance of late, with stocks of all different spots and stripes making the cut. Our Top Pick is Zscaler (ZS), which has lifted to new price and relative performance highs after a six-week pullback.

Stock Name	Price	Buy Range	Loss Limit
Atlassian (TEAM)	415	392-405	360-365
Cameco Corporation (CCJ)	26	25-27	21.5-22.5
Continental Resources (CLR)	52	49-51	42.5-43.5
Datadog (DDOG)	157	152-158	135-138
MGM Resorts (MGM)	48	47-48.5	42.5-43.5
Range Resources (RRC)	24	21.5-23	18.5-19
Snowflake (SNOW)	338	322-333	286-292
Tesla, Inc. (TSLA)	870	845-865	760-770
XENE (XENE)	31	29.5-31.5	25-26
Zscaler (ZS)	301	292-302	262-268

FedEx (FDX) reports earnings later today and all will be watching as its shares tumbled last week after it issued a sales warning. The Federal Reserve issued its fifth interest rate hike of 2022, and it certainly won’t be the last one, warned dove-turned-hawk Fed Chairman Jerome Powell. This brisk run-up in rates, which should have been earlier and faster, is hitting growth stocks hard since those are mostly high revenue growth companies that are not yet profitable. The market is punishing this group to levels that tempt longer-term investors.

Thank you for subscribing to the Cabot Value Investor. We hope you enjoy reading the July 2023 issue.

Almost like an annual rite of passage, major banks reported their Federal Reserve stress test results last week. All major banks passed, in that their capital levels were in excess of the minimum requirements under the Doomsday Scenario conditions outlined in the test assumptions. We’re not the biggest fans of these tests, for reasons outlined in our monthly letter.

Citigroup remains a riskier bank relative to other majors, but also has a higher return-potential share valuation, plus a 4.5% dividend yield to reward patient investors.

We’re only a week into the new year, but it’s been a good start for your value stocks. On average, prices of the stocks on the recommended list (excluding ARCO, which we sold last week) have increased nearly 7%. This is a favorable start, both in absolute terms and relative to the 3% jump in the S&P 500 Index.

Emerging market stocks have had a volatile week, with the iShares EM Fund (EEM) popping above its 25- and 50-day moving averages on Wednesday, but slipping back to the 50-day today.

You don’t hear much about it anymore, but the Internet of Things (IoT) affects many aspects of our lives. With that in mind, here are 3 IoT stocks to buy.

There’s been plenty of drama over the last week, but small caps don’t seem to care. Both the S&P 600 and the Russell 2000 are making new all-time highs.

FactSet reported this morning that the Russell 2000 has outperformed the S&P 500 Index every session this year. That’s impressive. Let’s look more closely at the S&P 600 Index because I have sector data for it. Impressively, through mid-day Thursday, every small-cap sector is outperforming its large-cap counterpart YTD. The strongest small-cap sectors are materials (+14.4%), energy (+13.4%), industrials (+12.3%), and tech (+11.7%). The weakest, utilities, financials and healthcare, are all up in the 4.4% to 5.3% range.

As a whole, the S&P 600 is up 9.2% while the S&P 500 is up just 1.2% YTD.